Symbol
BCTX on Nasdaq
Investment type
Equity / Common Stock, $0.01 par value
Latest Disclosed Shares Owned
190,006 shares
Security Ownership %
4.9%

3i, LP ownership in BriaCell Therapeutics Corp. Common Stock, $0.01 par value (BCTX)

13 May 2025 - 3i, LP has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 190,006 shares of BriaCell Therapeutics Corp. Common Stock, $0.01 par value (BCTX). This represents 4.9% ownership of the company. In their previous filing dated 10 Feb 2025, 3i, LP had reported owning 369,000 shares, indicating a decrease of +49%. .